Real-time RT-PCR and western blotting documented significantly elevated RUNX2 expression at days 7 and 14 in both the OM with TGFβ1 and OM with TGFβ2 groups compared with those from BMSCs maintained in OM alone (Figures 5C–F). Here, RUNX2 is linked to ocular melanoma.